Avinger Inc. (AVGR)
NASDAQ: AVGR
· Real-Time Price · USD
0.47
-0.13 (-21.40%)
At close: Feb 14, 2025, 3:59 PM
-21.40% (1D)
Bid | n/a |
Market Cap | 1.52M |
Revenue (ttm) | 7.26M |
Net Income (ttm) | -18.61M |
EPS (ttm) | -8.76 |
PE Ratio (ttm) | -0.05410958904109589 |
Forward PE | -0.64 |
Analyst | n/a |
Dividends | n/a |
Ask | n/a |
Volume | 2,592,021 |
Avg. Volume (20D) | 3,195,863 |
Open | 0.56 |
Previous Close | 0.60 |
Day's Range | 0.46 - 0.61 |
52-Week Range | 0.36 - 4.37 |
Beta | 1.09 |
Ex-Dividend Date | n/a |
About AVGR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVGR
Website n/a
Avinger Inc. is scheduled to release its earnings on
May 2, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+42.62%
Avinger shares are trading higher after the compan...
Unlock content with
Pro Subscription
9 months ago
+46.05%
Avinger shares are trading higher after the company announced it has received a Notice of Allowance for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."